Telescope Provides Update on Private Placement
March 21, 2025 — The Company is offering units (each, a “Unit”) at a price of $0.40 to raise gross proceeds of up to $3,000,000.
Telescope Innovations, Corporation to Present at the Virtual Life Science Investor Forum March 13th
March 11, 2025 — Telescope Innovations invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com
Telescope Innovations Advances Self-Driving Lab Deployment, Strengthening Industry Impact
February 24, 2025 — Telescope’s Self-Driving Lab (“SDL”) technology integrates AI, robotics, advanced analytics, and chemistry to accelerate research and development.
Telescope Innovations Commences Trading on the Frankfurt Stock Exchange
February 19, 2025 — Telescope Innovations common shares are now listed for trading on the Frankfurt Stock Exchange (“FSE”) under the ticker symbol “J4U”.
Telescope Innovations Founder and CTO, Professor Jason Hein, Honoured with 2025 R. U. Lemieux Award
February 10, 2025 — The Company generated revenues of $1.2 million during this period (Q3, 2024), and year-to-date revenues surpass entire fiscal year 2023.
Telescope Announces Private Placement
February 4, 2025 — The Company will conduct a non-brokered private placement (the “Offering”) under the Listed Issuer Financing Exemption of units of the Company (each, a “Unit”) to raise gross proceeds of up to $3,000,000.
Telescope Innovations Presents Results of First Fiscal Quarter 2025
January 27, 2025 — The Company generated revenues of $1.2 million during this period (Q3, 2024), and year-to-date revenues surpass entire fiscal year 2023.
Telescope Innovations Demonstrates Production of >99% Pure Lithium Carbonate from Widely Varied North American Brines
January 13, 2025 — Telescope’s proprietary ReCRFT™ process paves the way for on-shore production of battery raw materials.
Telescope Innovations Presents Continued Growth in Fiscal Year 2024
December 23, 2024 — Increased revenues fueled major research and commercialization projects for intelligent automation products and advanced chemical manufacturing.
Telescope Innovations Announces Scientific Publication on AI-Optimized Production of Battery-Grade Lithium Carbonate
October 29, 2024 — AI guides Telescope’s ReCRFT tech to boost efficiency and environmental sustainability of producing battery raw materials.
Telescope Innovations Becomes Certified Systems Integrator of Universal Robots
October 15, 2024 — Certification enables faster development and deployment of Telescope’s Self-Driving Labs.
Telescope Innovations and Altillion Inc. Showcase Proprietary, Simplified Production of Battery-Quality Lithium Carbonate from Brines
September 17, 2024 — Telescope’s proprietary ReCRFT process produces >99.5% pure lithium carbonate from Altillion’s brine concentrates
Telescope Innovations and Standard Lithium Demonstrate Low-Temperature, High-Purity Production of Lithium Sulfide for Solid-State Batteries
August 28, 2024 — Telescope Innovations utilized robotics and artificial intelligence to identify a novel, scalable route to produce lithium sulfide.
Telescope Innovations and Pfizer Sign Master Collaborative Research Agreement
July 31, 2024 — Pfizer and Telescope will develop Self-Driving Laboratories to accelerate pharmaceutical R&D through automation, robotics, and AI.
Telescope Innovations Receives CICE Funding to Pilot Lithium Refinement Technology
July 22, 2024 — Non-dilutive investment will support Telescope’s piloting of its proprietary Recrystallization Refinement Technology, ReCRFT™.
Telescope Innovations Presents Results of Third Fiscal Quarter 2024
July 11, 2024 — The Company generated revenues of $1.2 million during this period (Q3, 2024), and year-to-date revenues surpass entire fiscal year 2023.
Telescope Innovations Joins MaRS: North America’s Largest Urban Innovation Hub
June 24, 2024 — Relative to similar VC-backed ventures, MaRS member companies raise higher capital amounts, having secured over CAD $19B in cumulative investments since 2010.
Telescope Innovations to Participate in Lithium Supply and Battery Raw Materials Conference 2024
June 11, 2024 — Telescope will showcase proprietary lithium refinement technology (ReCRFT™), which generates battery-quality lithium carbonate from brines in a single step.
Telescope Innovations to Showcase DirectInject-LC™ Product and Process IP at METTLER TOLEDO Events
May 13, 2024 — Telescope will feature two proprietary innovations during the New Jersey and Montreal InfoDays hosted by METTLER TOLEDO.
Telescope Innovations Presents Results of Second Fiscal Quarter 2024
April 18, 2024 — The Company generated revenues of $686,205 during this period, driven by strong sales performance of its flagship product, DirectInject-LC™
Telescope Innovations Develops Novel Battery Recycling Technology
April 15, 2024 — Telescope’s new approach isolates lithium and valuable transition metals from battery recycling feeds.
Telescope Innovations and Shimadzu Scientific Instruments Initiate Technology Partnership
February 26, 2024 — Telescope pairs its DirectInject-LC™ technology with Shimadzu’s chemical analysis instrumentation.
Telescope Innovations Strengthens Senior Management: Henry Dubina Appointed as CEO, Dr. Jason Hein as CTO, John Kirincic as CFO, Deborah Cotter as Corporate Secretary
February 15, 2024 — We welcome Henry Dubina as CEO, John Kirincic as CFO, and Deborah Cotter as Corporate Secretary. Jason Hein transitions to CTO.
Mettler Toledo and Telescope Innovations Agree to Globally Distribute Telescope’s Flagship Product, DirectInject-LC™
February 5, 2024 — We have signed a Distribution Agreement with METTLER TOLEDO for Telescope’s online chemistry sampling and analysis product, the DirectInject-LC™.
Telescope Innovations Presents Results of First Fiscal Quarter 2024
January 30, 2024 — The Company generated revenues of $1.50 M for a net income of $215,000, exceeding its prior records.
Telescope Innovations Files Game-Changing Provisional Patent to Purify Battery Materials
January 23, 2024 — Telescope announces it has filed a provisional patent application on a disruptive new technique to purify lithium carbonate.
Telescope Innovations Reports Strong Growth in Fiscal Year 2023
December 22, 2023 — The Company generated revenues of $2.82 M, representing an increase of 375% over the previous fiscal year.
Telescope Innovations Develops New IP for the Production of Battery Materials
December 18, 2023 — Telescope has invented a low-temperature method of generating lithium sulfide from brine-sourced lithium chemicals.
Telescope Innovations and Mott Corporation Initiate Technology Partnership
October 30, 2023 — Telescope and Mott plan to develop and commercialize a novel robotic sampling probe for automated chemistry analysis.
Telescope Innovations Product Deployed by 13 Pharma Giants in First Year
October 4, 2023 — Telescope’s flagship technology, Direct Inject Liquid Chromatography (DILC), has been deployed at 13 of the top 20 pharmaceutical companies in the world.
Telescope Innovations is Granted a Canadian Patent on Chemical Synthesis Route
August 28, 2023 — Telescope’s first Canadian patent describes a scalable manufacturing process to produce pharmaceutically-relevant indole compounds.
Telescope Announces Stock Option Grants
August 3, 2023 — Telescope has granted 800,000 incentive stock options to certain directors of the Company in accordance with the Company’s incentive stock option plan.
Telescope Innovations Receives Accelerator Funding to Develop Carbon-Negative Production of Battery Materials
July 11, 2023 — Canada’s Mining Innovation Commercialization Accelerator (“MICA”) Network will fund Telescope’s efforts to develop lithium carbonate production methods that are carbon-negative.
Telescope Innovations Delivers Continued Profitability in Fiscal Quarter 3, 2023
June 29, 2023 — The Company generated revenues of $1.01M and a net income of $67,847 in Q3, 2023, representing an increase of 500% in net income over the previous quarter.
Telescope at CSC 2023
We will be out in full force at Canada’s largest chemistry conference this year. CSC 2023 is coming to our hometown of Vancouver, and here’s where catch us!
Telescope Reports Profitable Quarter: Fiscal Q2, 2023
April 25, 2023 — Just over one year after securing facilities, assembling a team, and outfitting a research laboratory, the Company delivered its first profitable quarter.
Telescope Reports First Fiscal Quarter 2023 Results
February 8, 2023 — Telescope is revenue-positive for a second consecutive quarter. Catch us at a series of upcoming investor events and technical conferences.
Telescope Presents 2022 Fiscal Year Highlights and Investor Update
January 23, 2023 — Telescope reports revenue in first full year of operation, a new project with Aqualung Carbon Capture, and upcoming events.
Telescope Announces Closing of $1.46 Million Non-brokered Private Placement
November 10, 2022 — Telescope intends to use the net proceeds from the Offering for working capital and general corporate purposes.
Takeaways From our Press Release on NRCan Project
October 31, 2022 — View PR highlights and watch the video on how this project supports Telescope’s goals
Telescope Announces Engagement with Natural Resources Canada to Develop Lithium Refinement Technology
October 24, 2022 — Telescope will collaborate with NRCan to build an autonomous, self-driving experimental platform for lithium refinement.
Second Nobel Prize Won by Telescope Innovations Advisor
October 6, 2022 — K. Barry Sharpless, a member of Telescope’s Scientific Advisory Board, was awarded the 2022 Nobel Prize in Chemistry.
Telescope welcomes Dr. Jeffrey Sherman as Chief Operating Officer
September 6, 2022 — Dr. Sherman brings over thirty years of experience in the scientific instrument industry, including work with Micromeritics Instrument Corporation, ThermoFisher Scientific, and Mettler-Toledo.
Telescope upgrades US listing to OTCQB
September 1, 2022 — We anticipate that our OTCQB listing will provide greater liquidity and a more seamless trading experience for our U.S. shareholders.
Contextualizing our completed research project funded by Pfizer
August 13, 2022 —We are deploying our unique technology platforms to resolve critical bottlenecks in the chemical and pharmaceutical industry.
Telescope completes feasibility research project funded by Pfizer
August 10, 2022 — We created a proof-of-concept robotic workflow leveraging our proprietary in-situ analytical technology and automation tools.
Telescope inks research agreement with Standard Lithium
July 13, 2022 — Telescope will initially work on developing CO2 utilization and sequestration technology.
Telescope launches first automation product
June 27, 2022 — The Direct Inject Liquid Chromatography (“DILC”) platform is an innovative instrument for real-time, immediate analysis of chemical reactions.
Telescope Announces Results of its Annual General Meeting
April 29, 2022 — Shareholders elected Prof. Jason Hein, Robert Mintak, James Andrew Robinson, Ali Pejman, and Henry Dubina as directors of the Company.
Telescope expects proposal for a new board member at upcoming AGM
April 26, 2022 — Henry Dubina, the ex-president and strategic business unit head of Mettler-Toledo Autochem, is expected to be nominated as an independent director of Telescope.
